Aaron Schacht

Aaron Schacht

Eli Lilly and Company - Indianapolis / United States
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 4390101
-
person_outline Aaron Schacht's MOST POPULAR ARTICLES
1-) How to improve R&D productivity: the pharmaceutical industry\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\'s grand challengeSM Paul, DS Mytelka, CT Dunwiddie, CC Persinger, BH Munos, ...Nature reviews Drug discovery 9 (3), 203-214, 201037612010
2-) Effect of different doses of galcanezumab vs placebo for episodic migraine prevention: a randomized clinical trialV Skljarevski, TM Oakes, QI Zhang, MB Ferguson, J Martinez, ...JAMA neurology 75 (2), 187-193, 20181472018
3-) Antithrombotic agentsAL Schacht, GF Smith, MR WileyUS Patent 5,705,487, 1998681998
4-) Antithrombotic agentsAL Schacht, GF Smith, MR WileyUS Patent 5,710,130, 1998561998
5-) Antithrombotic agentsAL Schacht, GF Smith, MR WileyUS Patent 5,707,966, 1998521998